Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-17 4:01 pm Purchase | 2025-12-16 | 13G | Jade Biosciences, Inc. JBIO | Bellevue Group AG | 3,341,103 6.800% | 3,341,103 (New Position) | Filing History |
| 2026-01-06 7:27 pm Sale | 2025-12-05 | 13G | MacroGenics, Inc. MGNX | Bellevue Group AG | 0 0.000% | -9,929,963 (Position Closed) | Filing History |
| 2025-12-05 5:42 pm Sale | 2025-11-19 | 13G | Agios Pharmaceuticals, Inc. AGIO | Bellevue Group AG | 0 0.000% | -3,515,150 (Position Closed) | Filing History |
| 2025-11-14 8:00 pm Purchase | 2025-08-20 | 13G | Immunocore Holdings plc IMCR | Bellevue Group AG | 2,796,803 5.600% | 2,796,803 (New Position) | Filing History |
| 2025-11-14 7:58 pm Purchase | 2025-08-18 | 13G | Celldex Therapeutics, Inc. CLDX | Bellevue Group AG | 3,617,669 5.400% | 3,617,669 (New Position) | Filing History |
| 2025-07-07 7:32 pm Purchase | 2025-06-01 | 13G | Agios Pharmaceuticals, Inc. AGIO | Bellevue Group AG | 3,515,150 6.100% | 3,515,150 (New Position) | Filing History |
| 2025-07-07 7:20 pm Purchase | 2025-06-01 | 13G | MacroGenics, Inc. MGNX | Bellevue Group AG | 9,929,963 15.700% | 9,929,963 (New Position) | Filing History |
| 2024-11-14 7:34 pm Sale | 2024-09-30 | 13G | Accolade, Inc. ACCD | Bellevue Group AG | 640,865 0.800% | -3,866,539 (-85.78%) | Filing History |
| 2024-02-13 06:07 am Sale | 2023-12-31 | 13G | Outset Medical, Inc. OM | Bellevue Group AG | 117,342 3.500% | -72,236 (-38.10%) | Filing History |
| 2024-02-13 06:05 am Purchase | 2023-12-31 | 13G | Accolade, Inc. ACCD | Bellevue Group AG | 4,507,404 5.800% | 830,127 (+22.57%) | Filing History |
| 2023-02-14 5:26 pm Purchase | 2022-12-31 | 13G | Accolade, Inc. ACCD | Bellevue Group AG | 3,677,277 5.100% | 3,677,277 (New Position) | Filing History |
| 2023-02-14 5:18 pm Purchase | 2022-12-31 | 13G | Outset Medical, Inc. OM | Bellevue Group AG | 189,579 5.900% | 189,579 (New Position) | Filing History |